The University of Colorado Anschutz is part of a national study looking at the potential benefits and risks of psilocybin ...

Clay Holmes has made the transition from closer to starter look easy. He's 3-1 with a 2.64 ERA in six outings.

MSD has reported outcomes from a Phase III trial of Keytruda (pembrolizumab) for treating head and neck squamous cell ...

Many customer reviews confirmed that Okita Nail Fungus Light is far from a fraud because of its tried-and-true technology, ...

As pressure grows to get artificial colors out of the U.S. food supply, the shift may well start at Abby Tampow’s laboratory desk. On an April afternoon, the scientist hovered over tiny dishes of red ...

Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 ...

Kopran climbed 4.39% to Rs 198.35 after the company announced a successful closure of a US drug regulator's inspection at its subsidiary's API facility.

Marksans Pharma rose 1.9% to Rs 220.10 after the US Food and Drug Administration (USFDA) concluded its inspection of the company's subsidiary, Time-Cap Laboratories Inc.